NanoString nCounter: Analytical Validation (MD Anderson)
BRD ID: 3112
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 376
Description
This assay analytical validation and performance report describes the methods used to validate the nCounter Pan Cancer Panel in conjunction with the Nanostring's nCounter Analysis System using RNA isolated from formalin-fixed, paraffin-embedded (FFPE) tissue specimens. The document also presents data supporting the reported analytical sensitivity using RNA input amounts of 0-625 ng, intra- and inter-assay reproducibility, inter-operator reproducibility, analytical specificity, and differentiation between normal and tumor specimens. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at MD Anderson Cancer Center. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).
Biospecimens
TissueBreast
TissueLung
TissueTonsil
Diagnoses
NeoplasticCarcinoma
Normal
Topics
Platform-specific Methodology